Quent Capital’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Other funds holding JAZZ
Quent Capital's JAZZ Position: Q2 2026 in Review
Quent Capital increased its Jazz Pharmaceuticals (JAZZ) stake by 0.33% in Q2 2026, buying an estimated $219 and bringing the position to 308 shares worth $74.2K. The position accounts for ﹤0.01% of the portfolio, ranked #689.
Quent Capital first reported a position in JAZZ in Q4 2021 and has held it in 18 quarters since. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.
- Quent Capital held 308 shares of Jazz Pharmaceuticals worth $74.2K as of Q2 2026.
- Quent Capital bought 1 Jazz Pharmaceuticals share in Q2 2026, an estimated $219.
- Jazz Pharmaceuticals made up ﹤0.01% of Quent Capital's portfolio in Q2 2026, its #689 holding.
- Quent Capital first reported a position in Jazz Pharmaceuticals in Q4 2021 and has held it in 18 quarters since.
- 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.
Based on Quent Capital's 13F filing for Q2 2026, filed 7 Aug 2026.